SRSF2 safeguards efficient transcription of DNA damage and repair genes
Rebecca E. Wagner,
Leonie Arnetzl,
Thiago Britto-Borges,
Anke Heit-Mondrzyk,
Ali Bakr,
Etienne Sollier,
Nikoletta A. Gkatza,
Jasper Panten,
Sylvain Delaunay,
Daniela Sohn,
Peter Schmezer,
Duncan T. Odom,
Karin Müller-Decker,
Christoph Plass,
Christoph Dieterich,
Pavlo Lutsik,
Susanne Bornelöv,
Michaela Frye
Affiliations
Rebecca E. Wagner
Division of Mechanisms Regulating Gene Expression, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, 69117 Heidelberg, Germany
Leonie Arnetzl
Division of Mechanisms Regulating Gene Expression, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Thiago Britto-Borges
Section of Bioinformatics and Systems Cardiology, Department of Internal Medicine III and Klaus Tschira Institute for Integrative Computational Cardiology, Heidelberg University Hospital, 69120 Heidelberg, Germany; German Centre for Cardiovascular Research (DZHK), Partner site Heidelberg/Mannheim, 69120 Heidelberg, Germany
Anke Heit-Mondrzyk
Division of Mechanisms Regulating Gene Expression, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Ali Bakr
Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Etienne Sollier
Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Nikoletta A. Gkatza
Department of Genetics, University of Cambridge, CB2 3EH Cambridge, UK
Jasper Panten
Faculty of Biosciences, Heidelberg University, 69117 Heidelberg, Germany; Division of Regulatory Genomics and Cancer Evolution, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Sylvain Delaunay
Division of Mechanisms Regulating Gene Expression, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Daniela Sohn
Division of Mechanisms Regulating Gene Expression, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Peter Schmezer
Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Duncan T. Odom
Division of Regulatory Genomics and Cancer Evolution, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Karin Müller-Decker
Division of Mechanisms Regulating Gene Expression, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Christoph Plass
Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Christoph Dieterich
Section of Bioinformatics and Systems Cardiology, Department of Internal Medicine III and Klaus Tschira Institute for Integrative Computational Cardiology, Heidelberg University Hospital, 69120 Heidelberg, Germany; German Centre for Cardiovascular Research (DZHK), Partner site Heidelberg/Mannheim, 69120 Heidelberg, Germany
Pavlo Lutsik
Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Department of Oncology, KU Leuven, 3000 Leuven, Belgium
Susanne Bornelöv
Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, CB2 0RE Cambridge, UK
Michaela Frye
Division of Mechanisms Regulating Gene Expression, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Corresponding author
Summary: The serine-/arginine-rich splicing factor 2 (SRSF2) plays pivotal roles in pre-mRNA processing and gene transcription. Recurrent mutations, particularly a proline-to-histidine substitution at position 95 (P95H), are common in neoplastic diseases. Here, we assess SRSF2’s diverse functions in squamous cell carcinoma. We show that SRSF2 deletion or homozygous P95H mutation both cause extensive DNA damage leading to cell-cycle arrest. Mechanistically, SRSF2 regulates efficient bi-directional transcription of DNA replication and repair genes, independent from its function in splicing. Further, SRSF2 haploinsufficiency induces DNA damage without halting the cell cycle. Exposing mouse skin to tumor-promoting carcinogens enhances the clonal expansion of heterozygous Srsf2 P95H epidermal cells but unexpectedly inhibits tumor formation. To survive carcinogen treatment, Srsf2 P95H+/− cells undergo substantial transcriptional rewiring and restore bi-directional gene expression. Thus, our study underscores SRSF2’s importance in regulating transcription to orchestrate the cell cycle and the DNA damage response.